
Financial overview
Here, you will find key insights into Rejlers’ financial performance, including revenue growth, profitability, and strategic developments. This section provides an overview of our financial results, reflecting our ongoing commitment to delivering value for our shareholders and driving sustainable growth in the engineering consultancy sector.
Five-year overview
Income statement summary, SEK millions | 2024 | 2023 | 2022 | 2021 | 20201) |
---|---|---|---|---|---|
Net sales | 4,430.7 | 4,088.3 | 3,513.0 | 2,898.7 | 2366.9 |
Other income | 16.5 | 19.7 | 10.5 | 8.8 | 15.3 |
Personnel expenses | –2,823.5 | –2,648.4 | –2,141.5 | –1,801.1 | –1,587.0 |
Other external expenses | –1,122.3 | –1,014.0 | –967.3 | –829.8 | –583.5 |
Participations in associated company earnings | 1.0 | 2.4 | 1.5 | 2.5 | 2.3 |
Depreciation/amortisation and impairment of non-current assets | –150.1 | –141.8 | –128.9 | –114.8 | –103.8 |
EBITA | 352.3 | 306.2 | 287.3 | 164.3 | 110.2 |
Acquisition-related items | –64.1 | –71.2 | –53.0 | –34.6 | –26.4 |
EBIT | 288.2 | 235.0 | 234.3 | 129.7 | 83.8 |
Net financial items | 4.2 | –8.3 | 11.5 | 6.3 | –34.0 |
Profit/loss after net financial items | 292.4 | 226.7 | 245.8 | 136.0 | 49.8 |
Tax | –70.6 | –41.3 | –49.4 | –25.8 | –17.3 |
PROFIT FOR THE YEAR FROM REMAINING OPERATIONS1) | 221.8 | 185.4 | 196.4 | 110.2 | 32.5 |
PROFIT FOR THE YEAR FROM DIVESTED OPERATIONS | – | – | – | – | 252.5 |
TOTAL REMAINING AND DIVESTED OPERATIONS | 221.8 | 185.4 | 196.4 | 110.2 | 285.0 |
1) 2020, remaining operations after the divestment of Embriq. | |||||
Balance sheet summary, SEK millions | 2024 | 2023 | 2022 | 2021 | 2020 |
Intangible assets | 1,953.2 | 1,941.0 | 1,450.0 | 1,047.3 | 912.9 |
Property, plant and equipment | 53.7 | 52.0 | 44.1 | 40.4 | 34.2 |
Rights of use | 326.8 | 270.2 | 275.1 | 270.7 | 283.5 |
Financial assets | 42.5 | 50.5 | 46.4 | 40.6 | 29.6 |
Deferred tax asset | 4.3 | 14.0 | 14.0 | 20.9 | 20.9 |
Current receivables | 1,249.9 | 1,262.0 | 1,010.0 | 777.9 | 621.1 |
Cash and cash equivalents | 68.6 | 59.2 | 144.8 | 151.9 | 336.6 |
Total assets | 3,699.0 | 3,648.9 | 2,984.4 | 2,349.7 | 2,238.9 |
Equity | 1,936.8 | 1,801.8 | 1,487.1 | 1,215.5 | 1,156.2 |
Non-current liabilities | 372.2 | 357.7 | 559.5 | 377.2 | 424.5 |
Current liabilities | 1,390.0 | 1,489.4 | 937.8 | 757.0 | 658.2 |
Total liabilities and equity | 3,699.0 | 3,648.9 | 2,984.4 | 2,349.7 | 2,238.9 |
Cash flow sheet summary, SEK millions | 2024 | 2023 | 2022 | 2021 | 20202) |
Cash flow from operating activities | 407.7 | 265.9 | 275.2 | 170.0 | 331.6 |
Cash flow from investing activities | –107.7 | –551.7 | –245.6 | –132.4 | 70.7 |
Cash flow from financing activities | –291.8 | 203.1 | –40.4 | –223.5 | –206.4 |
CASH FLOW FOR THE YEAR | 8.2 | –82.7 | –10.8 | –185.9 | 195.9 |
2) Including Embriq to Aug 2020. | |||||
Alternative performance measures1) | 2024 | 2023 | 2022 | 2021 | 20202) |
IFRS key performance indicators | |||||
Earnings per share before dilution, SEK/share | 10.03 | 8.39 | 9.64 | 5.60 | 1.65 |
Earnings per share after dilution, SEK/share | 10.03 | 8.32 | 9.55 | 5.47 | 1.61 |
Average number of shares, count | 22,106,849 | 21,675,599 | 20,207,411 | 19,687,909 | 19,687,909 |
Number of shares at the end of the period, count | 22,106,849 | 22,106,849 | 20,381,849 | 19,687,909 | 19,687,909 |
Growth | |||||
Organic growth, % | 4.8 | 5.0 | 11.7 | 11.8 | –2.2 |
Acquired growth, % | 3.9 | 8.7 | 7.4 | 11.8 | 11.2 |
Currency effect, % | –0.3 | 2.7 | 2.1 | –1.1 | –1.9 |
Profit/loss | |||||
Adjusted EBITA, SEK million | 362.3 | 326.2 | 287.3 | 182.5 | 128.6 |
Adjusted EBITA margin, % | 8.2 | 8.0 | 8.2 | 6.3 | 5.4 |
Items affecting comparability, SEK million | 10.0 | 20.0 | – | 18.2 | 18.4 |
EBITA, SEK million | 352.3 | 306.2 | 287.3 | 164.3 | 110.2 |
EBITA margin, % | 8.0 | 7.5 | 8.2 | 5.7 | 4.7 |
Operating profit/loss (EBIT), SEK million | 288.2 | 235.0 | 234.3 | 129.7 | 83.8 |
Operating margin, % | 6.5 | 5.7 | 6.7 | 4.5 | 3.5 |
Key performance indicators per employee | |||||
Sales per full-year employee, SEK thousand | 1,434 | 1,361 | 1,376 | 1,290 | 1,121 |
Operating profit/loss per full-year employee, SEK thousand | 93 | 78 | 92 | 58 | 40 |
Balance sheet | |||||
Net indebtedness, SEK million | 601.7 | 627.6 | 391.3 | 304.1 | 213.8 |
Net debt/EBITDA, multiple | 1.20 | 1.40 | 0.94 | 1.09 | 1.08 |
Equity/assets ratio, % | 52.4 | 49.4 | 49.8 | 51.7 | 51.6 |
Equity per share at the end of the period, SEK | 87.6 | 81.5 | 73.0 | 61.7 | 58.7 |
Return on equity, % | 15.6 | 13.8 | 18.2 | 11.5 | 26.1 |
Return on capital employed, % | 13.4 | 13.7 | 14.5 | 10.3 | 28.9 |
Other | |||||
Dividend per share, SEK3) | 4.5 | 4.5 | 3.0 | 6.5 | 0.0 |
Number of full-year employees, count | 3,090 | 3,004 | 2,553 | 2,247 | 2,110 |
Number of employees at end of period, count | 3,281 | 3,254 | 2,773 | 2,464 | 2,330 |
Utilisation, % | 79.3 | 79.6 | 80.7 | 79.2 | 76.0 |
1) 2020, remaining operations after the divestment of Embriq.
2) Including Embriq to Aug 2020.
3) For the 2025 AGM, the Board of Directors proposes a dividend of SEK 5.00 per share